180 related articles for article (PubMed ID: 25798997)
1. Quantification of ventricular repolarization heterogeneity during moxifloxacin or sotalol administration using [Formula: see text]-index.
Rivolta MW; Mainardi LT; Sassi R
Physiol Meas; 2015 Apr; 36(4):803-11. PubMed ID: 25798997
[TBL] [Abstract][Full Text] [Related]
2. Effect of a single oral dose of moxifloxacin (400 mg and 800 mg) on ventricular repolarization in healthy subjects.
Démolis JL; Kubitza D; Tennezé L; Funck-Brentano C
Clin Pharmacol Ther; 2000 Dec; 68(6):658-66. PubMed ID: 11180026
[TBL] [Abstract][Full Text] [Related]
3. Effect of levetiracetam on cardiac repolarization in healthy subjects: a single-dose, randomized, placebo- and active-controlled, four-way crossover study.
Hulhoven R; Rosillon D; Bridson WE; Meeus MA; Salas E; Stockis A
Clin Ther; 2008 Feb; 30(2):260-70. PubMed ID: 18343264
[TBL] [Abstract][Full Text] [Related]
4. [Sotalol, propafenone, and flecainide: compared multiparametric analysis of ventricular repolarization in subjects without organic cardiopathy].
Sarubbi B; Ducceschi V; Briglia N; Esposito R; Mayer MS; Scialdone A; Santangelo L; Iacono A
Cardiologia; 1996 Jul; 41(7):645-51. PubMed ID: 8983831
[TBL] [Abstract][Full Text] [Related]
5. Baseline values and sotalol-induced changes of ventricular repolarization duration, heterogeneity, and instability in patients with a history of drug-induced torsades de pointes.
Couderc JP; Kaab S; Hinterseer M; McNitt S; Xia X; Fossa A; Beckmann BM; Polonsky S; Zareba W
J Clin Pharmacol; 2009 Jan; 49(1):6-16. PubMed ID: 18957528
[TBL] [Abstract][Full Text] [Related]
6. Assessment of the effect of a single oral dose of telithromycin on sotalol-induced qt interval prolongation in healthy women.
Démolis JL; Strabach S; Vacheron F; Funck-Brentano C
Br J Clin Pharmacol; 2005 Aug; 60(2):120-7. PubMed ID: 16042664
[TBL] [Abstract][Full Text] [Related]
7. Application of a probabilistic method for the determination of drug-induced QT prolongation in telemetered cynomolgus monkeys: effects of moxifloxacin.
Holzgrefe HH; Cavero I; Buchanan LV; Gill MW; Durham SK
J Pharmacol Toxicol Methods; 2007; 55(3):227-37. PubMed ID: 17097307
[TBL] [Abstract][Full Text] [Related]
8. The effects of sotalol on ventricular repolarization during exercise.
Li J; Wang JA
J Zhejiang Univ Sci B; 2005 Apr; 6(4):249-53. PubMed ID: 15754421
[TBL] [Abstract][Full Text] [Related]
9. Investigating the effect of sotalol on the repolarization intervals in healthy young individuals.
Couderc JP; Zhou M; Sarapa N; Zareba W
J Electrocardiol; 2008; 41(6):595-602. PubMed ID: 18801493
[TBL] [Abstract][Full Text] [Related]
10. Electrocardiographic markers of repolarization heterogeneity during dofetilide or sotalol initiation for paroxysmal atrial fibrillation.
Sauer AJ; Kaplan R; Xue J; Dorsey P; Hayes M; Shah SJ; Passman R
Am J Cardiol; 2014 Jun; 113(12):2030-5. PubMed ID: 24793679
[TBL] [Abstract][Full Text] [Related]
11. Lack of effect of aprepitant or its prodrug fosaprepitant on QTc intervals in healthy subjects.
Marbury TC; Jin B; Panebianco D; Murphy MG; Sun H; Evans JK; Han TH; Constanzer ML; Dru J; Shadle CR
Anesth Analg; 2009 Aug; 109(2):418-25. PubMed ID: 19608812
[TBL] [Abstract][Full Text] [Related]
12. Rate dependence of sotalol-induced prolongation of ventricular repolarization during exercise in humans.
Funck-Brentano C; Kibleur Y; Le Coz F; Poirier JM; Mallet A; Jaillon P
Circulation; 1991 Feb; 83(2):536-45. PubMed ID: 1846784
[TBL] [Abstract][Full Text] [Related]
13. Mexiletine antagonizes effects of sotalol on QT interval duration and its proarrhythmic effects in a canine model of torsade de pointes.
Chézalviel-Guilbert F; Davy JM; Poirier JM; Weissenburger J
J Am Coll Cardiol; 1995 Sep; 26(3):787-92. PubMed ID: 7642874
[TBL] [Abstract][Full Text] [Related]
14. Covariate analysis of QTc and T-wave morphology: new possibilities in the evaluation of drugs that affect cardiac repolarization.
Graff C; Struijk JJ; Matz J; Kanters JK; Andersen MP; Nielsen J; Toft E
Clin Pharmacol Ther; 2010 Jul; 88(1):88-94. PubMed ID: 20485337
[TBL] [Abstract][Full Text] [Related]
15. An estimate of the dispersion of repolarization times based on a biophysical model of the ECG.
Sassi R; Mainardi LT
IEEE Trans Biomed Eng; 2011 Dec; 58(12):3396-405. PubMed ID: 21878404
[TBL] [Abstract][Full Text] [Related]
16. Assessment of the sensitivity of detecting drug-induced QTc changes using subject-specific rate correction.
Cassani González R; Engels EB; Dubé B; Nadeau R; Vinet A; LeBlanc AR; Sturmer M; Becker G; Kus T; Jacquemet V
J Electrocardiol; 2012; 45(6):541-5. PubMed ID: 22960165
[TBL] [Abstract][Full Text] [Related]
17. Gender differences in cardiac repolarization following intravenous sotalol administration.
Somberg JC; Preston RA; Ranade V; Cvetanovic I; Molnar J
J Cardiovasc Pharmacol Ther; 2012 Mar; 17(1):86-92. PubMed ID: 21527783
[TBL] [Abstract][Full Text] [Related]
18. Improving the detection of subtle I(Kr)-inhibition: assessing electrocardiographic abnormalities of repolarization induced by moxifloxacin.
Couderc JP; McNitt S; Hyrien O; Vaglio M; Xia X; Polonsky S; Moss AJ; Zareba W
Drug Saf; 2008; 31(3):249-60. PubMed ID: 18302449
[TBL] [Abstract][Full Text] [Related]
19. Sample size, power calculations, and their implications for the cost of thorough studies of drug induced QT interval prolongation.
Malik M; Hnatkova K; Batchvarov V; Gang Y; Smetana P; Camm AJ
Pacing Clin Electrophysiol; 2004 Dec; 27(12):1659-69. PubMed ID: 15613131
[TBL] [Abstract][Full Text] [Related]
20. Highly automated QT measurement techniques in 7 thorough QT studies implemented under ICH E14 guidelines.
Couderc JP; Garnett C; Li M; Handzel R; McNitt S; Xia X; Polonsky S; Zareba W
Ann Noninvasive Electrocardiol; 2011 Jan; 16(1):13-24. PubMed ID: 21251129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
